About the Swiss Hemophilia Network (SHN)
History of the SHN:
The treatment of bleeding disorders has developed enormously in medical and pharmacological terms over the last decades and years. Nevertheless, people with bleeding disorders and their physicians have been confronted with major challenges in recent years. Experts agreed that comprehensive somatic, psychological and social care should be one of the cornerstones of modern treatment. However, the implementation of such a comprehensive care and treatment concept required an excessively high degree of flexibility and willingness to communicate in order to coordinate appropriate measures for the benefit of the patients.
This situation called for a new umbrella organization, which was defined as the Swiss Hemophilia Network in April 2014 from the (long-standing) Medical Commission (AeK) of the patient organization SHA (Swiss Hemophilia Association), in its current form.
The creation of this organization was a pioneering task in Switzerland. The SHN was the first association to form a network of medical, nursing, physiotherapy and other relevant professional groups in order to use interdisciplinary cooperation as an important basis for comprehensive treatment of this patient group.
Organization:
The focus of the new organization was on the logistical and linguistic conditions of people with bleeding disorders and their relatives. The SHN therefore created an organizational division of the various hemophilia centers into geographical units of the southeastern, western or centrally located centers in Switzerland.
This is how the present organizational units were created:
Aim of the SHN:
The aim of the Swiss Haemophilia Network is to offer optimal and comprehensive treatment to adults and children with congenital and acquired bleeding disorders in Switzerland.
These are our measures:
Bylaws:
Please click to download: Bylaws
Organs:
As a registered association, the Swiss Haemophilia Network has the following organs: the board of directors, the general meeting, the auditors and permanent commissions or working groups.
The Board consists of the Presidium and two members each (one from adult medicine and one from pediatrics) from the following geographical units:
– Middle (Hemophilia Centers Aarau, Basel, Bern, Lucerne)
– Southeast Switzerland (Hemophilia Centers Chur, St. Gallen, Bellinzona, Zurich)
– Westschweiz (Hemophilia Centers Geneva, Lausanne, Sion).
Members of the SHN:
Full members:
Experts who are actively involved in the treatment of patients with hemophilia or other congenital or acquired bleeding tendencies in Switzerland can be admitted as full members.
Honorary members:
Personalities who have rendered outstanding services in the field of hemophilia and to the SHN may be appointed honorary members. They have no voting rights.
Become a member:
The network is open to all professional groups, which are directly and actively involved in the treatment of people with bleeding tendencies. A membership costs an annual fee of 100, — CHF for Hematologists and Physician and 50,- CHF for Nurses, Physiotherapists and others.
Board:
Chair
Dr. med. Johanna Kremer Hovinga
Board Member
Colette Widmer, Physiotherapist
Board Member
Dr. med. Lukas Graf
Board Member
Prof. Dr. med. Manuela Albisetti
Board Member
Dr. med. Mattia Rizzi
Board Member
Prof. Dr. med. Lorenzo Alberio
Board Member
Prof. Dr. med. Nicolas von der Weid